Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Stefan P Kastl"'
Autor:
Stefan P Kastl, Katharina M Katsaros, Konstantin A Krychtiuk, Gerlinde Jägersberger, Christoph Kaun, Kurt Huber, Johann Wojta, Walter S Speidl
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232483 (2020)
BACKGROUND:Percutaneous coronary intervention represents the most important treatment modality of coronary artery stenosis. In-stent restenosis (ISR) is still a limitation for the long-term outcome despite the introduction of drug eluting stents. It
Externí odkaz:
https://doaj.org/article/e62bb54f373f4f0fb13b7d8549f82cb7
Autor:
Katharina M Katsaros, Walter S Speidl, Svitlana Demyanets, Stefan P Kastl, Konstantin A Krychtiuk, Anna Wonnerth, Gerlinde Zorn, Ioannis Tentzeris, Serdar Farhan, Gerald Maurer, Johann Wojta, Kurt Huber
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142532 (2015)
Granulocyte-colony-stimulating-factor (G-CSF) induces mobilization of progenitor cells but may also exert pro-inflammatory and pro-thrombotic effects. Treatment with recombinant G-CSF after acute myocardial infarction is currently under examination a
Externí odkaz:
https://doaj.org/article/7979c50d79b04260876b4d1296afbf6d
Autor:
Konstantin A Krychtiuk, Stefan P Kastl, Stefan Pfaffenberger, Max Lenz, Sebastian L Hofbauer, Anna Wonnerth, Lorenz Koller, Katharina M Katsaros, Thomas Pongratz, Georg Goliasch, Alexander Niessner, Ludovit Gaspar, Kurt Huber, Gerald Maurer, Elisabeth Dostal, Johann Wojta, Stanislav Oravec, Walter S Speidl
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123367 (2015)
Atherosclerosis is considered to be an inflammatory disease in which monocytes and monocyte-derived macrophages play a key role. Circulating monocytes can be divided into three distinct subtypes, namely in classical monocytes (CM; CD14++CD16-), inter
Externí odkaz:
https://doaj.org/article/577b432d961e453085e302f7971d7033
Autor:
Christian Gerges, Anna-Maria Pistritto, Mario Gerges, Richard Friewald, Valerie Hartig, Thomas M. Hofbauer, Benedikt Reil, Leon Engel, Varius Dannenberg, Stefan P. Kastl, Nika Skoro-Sajer, Bernhard Moser, Shahrokh Taghavi, Walter Klepetko, Irene M. Lang
Publikováno v:
Journal of the American College of Cardiology. 81:653-664
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b39680d128688237c227799cb3bbe11
https://doi.org/10.1016/j.jacc.2022.11.049
https://doi.org/10.1016/j.jacc.2022.11.049
Autor:
Theresa Bucsics, Georg Semmler, Philipp Schwabl, Bernhard Scheiner, Rafael Paternostro, Michael Trauner, Lukas Hartl, Christopher Desbalmes, Thomas Reiberger, Stefan P. Kastl, Dunja Schaufler, Markus Peck-Radosavljevic, Ernst Eigenbauer, Mattias Mandorfer, Rodrig Marculescu, Benedikt Simbrunner, Thomas Szekeres, David Bauer, Mathias Jachs
Publikováno v:
Hepatology International
Background and aims The cardiovascular hormones renin/angiotensin/aldosterone (RAA), brain-type natriuretic peptide (BNP)and arginine-vasopressin (AVP) are key regulators of systemic circulatory homeostasis in portal hypertension (PH). We assessed (i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede7a9ba5d42a980fc18c3911a335be3
https://doi.org/10.1007/s12072-021-10203-9
https://doi.org/10.1007/s12072-021-10203-9
Autor:
Stefan P. Kastl, Philipp J. Hohensinner, Max Lenz, Johann Wojta, Stanislav Oravec, Kurt Huber, Lore Schrutka, Christian Hengstenberg, Klaus Distelmaier, Konstantin A. Krychtiuk, Elisabeth Dostal, Walter S. Speidl
Publikováno v:
Journal of Clinical Lipidology. 15:512-521
BACKGROUND Proprotein convertase subtilisin/kexin type-9 (PCSK9) is an enzyme promoting the degradation of low-density lipoprotein receptors (LDL-R) in hepatocytes. Inhibition of PCSK9 has emerged as a novel target for lipid-lowering therapy. Monocyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9516ce3970e90b6f4662b9323db2a373
https://doi.org/10.1016/j.jacl.2021.02.005
https://doi.org/10.1016/j.jacl.2021.02.005
Autor:
Martin Hülsmann, Jutta Bergler-Klein, Mariann Gyöngyösi, Stefan P. Kastl, Noemi Pavo, Henrike Arfsten, Emilie Han, Maria K. Frey
Publikováno v:
Cardio-oncology
Cardio-Oncology, Vol 7, Iss 1, Pp 1-6 (2021)
Cardio-Oncology, Vol 7, Iss 1, Pp 1-6 (2021)
Background Sacubitril/valsartan has been shown to significantly reduce cardiovascular mortality and hospitalizations due to heart failure in patients with reduced ejection fraction (HFrEF) when compared to enalapril. Data about sacubitril/valsartan i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b44af528d9ae8f8472485c9f5c06a9f
https://doi.org/10.1186/s40959-021-00121-y
https://doi.org/10.1186/s40959-021-00121-y
Autor:
Konstantin A. Krychtiuk, Gottfried Heinz, Max Lenz, Alexander Nürnberger, Michael Schwameis, Walter S. Speidl, Bernhard Richter, Johann Wojta, Stefan P. Kastl, Christoph Schriefl, Thomas Uray
Publikováno v:
Resuscitation. 143:22-28
Early prognostication in post-cardiac arrest (CA) patients remains challenging and biomarkers have evolved as helpful tools in risk assessment. The stress-response cytokine growth differentiation factor-15 (GDF-15) is dramatically up-regulated during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ecf309fd06ad8f5a4a56a9da882a012
https://doi.org/10.1016/j.resuscitation.2019.07.028
https://doi.org/10.1016/j.resuscitation.2019.07.028
Autor:
Johann Wojta, Konstantin A. Krychtiuk, Georg Goliasch, Walter S. Speidl, Max Lenz, Kurt Huber, Stefan P. Kastl, Gottfried Heinz, Klaus Distelmaier
Publikováno v:
Shock. 51:410-415
Background Acute heart failure and cardiogenic shock are associated with an impaired intestinal perfusion, which may lead to a release of cytoplasmatic proteins by hypoxic epithelial injury. Intestinal fatty acid binding protein (iFABP), highly speci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21552e34fff5a6fafc1be6059977f988
https://doi.org/10.1097/shk.0000000000001195
https://doi.org/10.1097/shk.0000000000001195
Autor:
Philipp J. Hohensinner, Max Lenz, Christian Hengstenberg, Klaus Distelmaier, Lore Schrutka, Kilian Huber, Konstantin A. Krychtiuk, Walter S. Speidl, Stefan P. Kastl, Johann Wojta
Publikováno v:
European Journal of Preventive Cardiology. 28
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): FWF Background and aims Proprotein convertase subtilisin/kexin type-9 (PCSK9) is an enzyme promoting the degradation of low-density li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac2d3b721e4121f00c8ffc432fa1159
https://doi.org/10.1093/eurjpc/zwab061.278
https://doi.org/10.1093/eurjpc/zwab061.278